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Introduction
Staphylococcus aureus (S. aureus) is a common patho- 
 gen and can cause different kinds of infection in both 
hospitals and communities (Knox et al., 2015; Samanta 
et al., 2015). Several parts of human body can carry 
S. aureus and the nasal cavity is the main part. It was 
reported that S. aureus nasal carriage can increase the 
possibility of infection (Wertheim et al., 2005). Methi-
cillin-resistant Staphylococcus aureus (MRSA) was first 
discovered in 1961 and then widely spread around 
the world (Chen et al., 2012; Hernandez-Porto et al., 
2015). In the United States, the proportion of methi-
cillin resistance in S. aureus strains approached almost 
60% in 2003, with an average resistance rate of approxi-
mately 50% over the period from 1998 to 2002 (NNIS, 
2004). In Europe, the proportion of methi cillin resist-
ance in S. aureus strains isolated from infected patients 
increased from 21% in 2002 to 23% in 2005 and then 
decreased to 19% in 2008. Between 2002 and 2005, 
the annual increase was 7.6%, followed by an average 
annual decrease of 4.8% (de Kraker et al., 2013).
MRSA can increase the mortality rate, prolong hos-
pitalization and aggravate the economic burden (Gast-
meier et al., 2012; Lodise and McKinnon, 2005). MRSA 
infection, hepatitis B and Acquired Immune Defi- 
ciency Syndrome has currently become three global 
infectious diseases.
Diabetes is a common chronic disease. With the 
development of social economy, the improvement of 
living standard and the aging of population, the num-
ber of diabetic population is increasing worldwide. The 
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A b s t r a c t
Diabetic population were reported more likely to suffer carriage and infection with Staphylococcus aureus (S. aureus) and methicillin-
resistant Staphylococcus aureus (MRSA) than non-diabetic population. We aim to elucidate the prevalence and characteristics of S. aureus 
and MRSA nasal carriage among diabetic population in the United States National Health and Nutrition Examination Survey, 2001–2004. 
Univariate analyses were conducted using Chi-square test, Fisher’s exact probability test or student t test, as appropriate. Multivariate analy-
sis using logistic regression was conducted to assess the association between influencing factors and S. aureus and MRSA nasal carriage. 
1010 diabetic participants were included in the study. The prevalence of S. aureus and MRSA nasal carriage were 28.32% and 1.09%, respec-
tively. After the logistic regression, ever had a painful sensation or tingling in hands or feet past three months (Odds Ratio [OR] = 0.359, 
95% Confidence Interval [CI], 0.146–0.882) was significant among S. aureus nasal carriage and gender (OR = 3.410, 95% CI, 1.091–10.653) 
was significant among MRSA nasal carriage. The proportions of staphylococcal enterotoxin (SE) A, SEB, SEC, SED, Toxic-shock syn-
drome toxin-1, and Panton Valentine Leukocidin toxin among S. aureus strains were 18.75%, 3.13%, 12.50%, 15.63%, 28.13%, and 9.38%, 
respectively. 63.63% of MRSA strains were community-acquired, 27.27% were hospital-acquired, and 9.09% were non-typeable. Diabetic 
patients might be more likely to carry S. aureus and MRSA in the United States. Improving hand hygiene compliance, reducing antibiotic 
overuse, screening for carriers, and decolonization are recommended to reduce the spread of S. aureus and MRSA, especially in community.
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International Diabetes Federation Annual Report in 
2014 showed that 387 million people were estimated 
to be living with diabetes, an alarming number that is 
set to rise to 592 million within the next twenty years. 
A further 316 million with impaired glucose tolerance 
are at high risk from the disease, with projections indi-
cating that over one billion people will be living with 
or at high risk of diabetes in 2035 (IDF, 2014). Due 
to poor long-term blood glucose control or various 
complications, diabetic population is prone to suffer 
S. aureus or MRSA infection, which can cause death 
to a certain extent. Several studies reported that dia-
betes can increase S. aureus and MRSA carriage and 
infection (Chen and Pass, 2013; Daeschlein et al., 2015). 
In other words, diabetic population was more likely to 
suffer carriage and even infection with MRSA than 
non-diabetic population. 
There were a few studies focusing on S. aureus and 
MRSA nasal carriage among diabetic population and 
the conclusions were different. A Turkey study reported 
that the rates of S. aureus and MRSA nasal carriage 
among diabetic outpatient population were 41.9% 
(127/304) and 0.87% (30/304), respectively (Kutlu et al., 
2012). An Indian study reported that the S. aureus nasal 
carriage rate among hospitalized diabetic patients was 
56.6% (34/60) (Ahluwalia et al., 2000). A Chinese study 
reported that the rates of S. aureus and MRSA nasal car-
riage among hospitalized diabetic patients were 20.5% 
(41/200) and 0.50% (1/200), respectively (Junhua et al., 
2005). These studies, however, mainly focused on the 
prevalence and risk factors of S. aureus and MRSA nasal 
carriage among diabetic population, which were not 
comprehensive. Therefore, the objective of this cur-
rent study was to elucidate the prevalence, influenc-
ing factors, antibiotic resistance, toxin, and molecular 
characteristics of S. aureus and MRSA nasal carriage 
among diabetic population who participated in the 
United States National Health and Nutrition Exami-
nation Survey (NHANES), 2001–2004.
Experimental
Materials and Methods
Study design and population. The continuous 
NHANES is a large, annual, cross-sectional survey that 
is designed to evaluate the nutrition and health status of 
the US population. The surveys were approved by the 
National Center for Health Statistics Research Ethics 
Review Board. Data releases are available in two-year 
increments. The S. aureus and MRSA nasal carriage 
data were only collected from this NHANES 2001–2004 
dataset, so we used these data for analyzing. All par-
ticipants provided written informed consent and the 
research ethics boards of the National Center for Health 
Statistics approved all protocols. More details regarding 
the informed consent of subjects, survey design, data 
collection, data procedures and laboratory assessment 
can be found elsewhere (CDC). Those who were tested 
the assessment of S. aureus and were self-reported dia-
betes were included in the current study.
Assessment of prevalence of S. aureus and MRSA. 
Assessment of S. aureus was conducted for the entire 
sample, thus, all participants aged one year or older 
were tested. Specimens collected from the nares were 
plated on mannitol salt agar, a selective medium for 
the isolation of S. aureus. After overnight cultures, 
specimens were used to perform Staphaurex and tube 
coagulase test. Staphaurex-positive and tube coagulase-
positive isolates were identified as S. aureus and saved 
for further testing. S. aureus isolates were screened for 
methicillin resistance by the disk diffusion method of the 
National Clinical and Laboratory Standards Institute.
Diagnosed diabetes status. Diagnosed diabetes 
was identified in participants who answered “yes” to 
the self-reported question, “Have you ever been told by 
a doctor or health professional that you had diabetes?” 
and/or who used diabetes medication (i.e. oral hypo-
glycemic agents and/or insulin).
Potential influencing factors. Several variables 
were investigated as potential characteristics indica-
tive of nasal carriage of S. aureus and MRSA among 
diabetic population. These factors included the self-
reported diabetic characteristics variables, self-reported 
demographic variables, body measures variables, self-
reported current health variables, self-reported medical 
conditions variables, self-reported alcohol use variables, 
self-reported drug use variables, self-reported physi-
cal activity variables, self-reported prescription medi- 
cations variables, and self-reported exposure to ciga- 
rette smoke (operationalized as either being a smoker 
or living in a house with a current smoker). Given the 
limited population carriage of MRSA, we investigated 
a limited number of characteristics based on whether 
the sample size was large enough to make a reliable 
population estimate.
Assessment of antibiotic resistance of S. aureus 
and MRSA. Antibiotic resistance of S. aureus and MRSA 
was through antibiotic susceptibility testing by broth 
microdilution using Clinical and Laboratory Standards 
Institute reference methods. We calculated the resist-
ance of 18 common antibiotics including tetracycline, 
clindamycin, erythromycin, penicillin, imipenem, van-
comycin, cefazolin, oxacillin, gentamicin, ciprofloxacin, 
levofloxacin, rifampin, amoxicillin, chloramphenicol, 
doxycycline, daptomycin, quinupristin-dalfopristin, 
and linezolid. Moreover, we calculated multidrug resist-
ance (MDR), which was defined as resistant to three or 
more antibiotics with different mechanisms of action 
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(note that these strains are already resistant to all beta-
lactam antibiotics).
Assessment of toxin characteristics and molecu-
lar characteristics of S. aureus and MRSA. Strain typ-
ing by singleplex polymerase chain reaction (PCR) for 
detection of staphylococcal enterotoxins (SEs), toxic 
shock syndrome toxin-1 (TSST-1), Panton-Valentine 
Leukocidin (PVL) toxin, and staphylococcal cassette 
chromosome mec (SCCmec) type. SCCmec type is an 
important classification of MRSA that can be used to 
trace the source of the bacteria. According to some 
international reports, SCCmec I–III are designated as 
hospital-acquired (HA), SCCmec IV and V are desig-
nated as community-acquired (CA), and others are des-
ignated as non-typeable (NT) strains (Ito et al., 2003; 
Okuma et al., 2002). Although there have been studies 
(Freitas et al., 2010) that reported possible misclassifica-
tion errors for this typing, we still referenced it because 
there are no other accurate classifications.
 Statistical analysis. Means and standard errors 
were calculated for continuous variables, and frequen-
cies (percentages) were calculated for categorical vari-
ables. Univariate analyses were conducted using Chi-
square test, Fisher’s exact probability test or student 
t test, as appropriate. Multivariate analysis using logis-
tic regression was conducted to assess the association 
between influencing factors and S. aureus and MRSA 
nasal carriage. We also conducted a logistic regres-
sion analysis of all variables with a P value of < 0.10 
and then removed variables with a P value of ≥ 0.10. 
All statistical analyses were two-sided. All the statisti-
cal analyses were performed using Stata 13.1 (College 
Station, Texas, USA).
Results
Prevalence of S. aureus and MRSA nasal carriage. 
According to the inclusion criteria of study popu- 
lation there were 1010 diabetic population included 
in the current study. The prevalence of S. aureus, 
MRSA, and methicillin-sensitive Staphylococcus aureus 
(MSSA) nasal carriage were 28.32% (286/1010), 1.09% 
(11/1010), and 27.23% (275/1010) respectively. 
Influencing factors of S. aureus and MRSA nasal 
carriage. We found that military status (P = 0.027), 
marital status (P = 0.001), ever still had a liver condition 
(P = 0.033), ever had cancer or malignancy (P = 0.038), 
ever blood relatives had diabetes (P = 0.030), ever taken 
antibiotics past month (P = 0.017), ever taken diabetic 
pills to lower blood sugar (P = 0.040), ever had numb-
ness (P = 0.071), ever had a painful sensation or tingling 
in hands or feet past three months (P = 0.026), number 
of days used street drugs over past year (P < 0.001), and 
ever had five or more drinks every day (P = 0.043) were 
associated with S. aureus nasal carriage among diabetic 
population in this current study.
Gender (P = 0.068), number of alcoholic drinks per 
day over past 12 months (P = 0.048), number of days 
had five or more drinks past 12 months (P = 0.036), 
ever had vigorous activity past 30 days (P = 0.070), 
ever had moderate activity past 30 days (P = 0.081), 
frequency of playing or exercising hard every week 
(P = 0.050), and number of hours using TV, video or 
computer every day (P = 0.002) were associated with 
MRSA nasal carriage among diabetic population in this 
current study. More details can be found in Table I and 
Supplementary materials.
To account for potential confounding among the 
influencing factors, we further analyzed the relationship 
between the potential predictors with a logistic regres-
sion model. This model showed that when controlling 
for the effect of the other influencing factors, the rela-
tionships found in the univariate analyses changed. 
Ever had a painful sensation or tingling in hands or 
feet past three months was still associated with S. aureus 
nasal carriage among diabetic population in this logistic 
regression model. Having a painful sensation or tin-
gling in hands or feet past three months was a protec-
tive factor. Having a painful sensation or tingling in 
hands or feet past three months among diabetic popula-
tion were 0.359 times (95% Confidence Interval [CI], 
0.146–0.882) less likely than those not having a pain-
ful sensation or tingling in hands or feet past three 
months to carry S. aureus. Gender was still associated 
with MRSA nasal carriage among diabetic population 
in this logistic regression model. Female was a risk fac-
tor. Female diabetic population was 3.410 times (95% 
CI, 1.091–10.653) more likely than male diabetic popu-
lation to carry MRSA. More details can be found in 
Table II and Table III.
Antibiotic resistance of S. aureus nasal carriage. 
Among the proportions of antibiotic resistance in MRSA 
strains, penicillin (100.00%), imipenem (100.00%), cefa-
zolin (100.00%), oxacillin (100.00%), and amoxicillin 
(100.00%) were the highest, followed by erythromycin 
(72.73%), tetracycline (27.27%), levofloxacin (27.27%), 
clindamycin (18.18%), chloramphenicol (11.11%), van-
comycin (0.00%), gentamicin (0.00%), ciprofloxacin 
(0.00%), rifampin (0.00%), doxycycline (0.00%), dapto-
mycin (0.00%), quinupristin-dalfopristin (0.00%), and 
linezolid (0.00%). Specially, there was no MRSA strain 
resistant to vancomycin, gentamicin, ciprofloxacin, 
rifampin, doxycycline, daptomycin, quinupristin-dalfo-
pristin, and linezolid. Among the proportions of antibi-
otic resistance in MSSA strains, erythromycin (90.48%) 
and penicillin (90.48%) were the highest, followed 
by tetracycline (0.00%), vancomycin (0.00%), clinda-
mycin (0.00%), imipenem (0.00%), cefazolin (0.00%), 
oxacillin (0.00%), gentamicin (0.00%), ciprofloxacin 
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Table I
Significant influencing factors of Staphylococcus aureus and MRSA nasal carriage
Influencing factors Number of population
Staphylococcus aureus MRSA
Number (%) χ2 PNumber (%) χ2 P
Gender    – –  3.340 0.068
 Male  553 155 (28.03)    3 (1.94)  
 Female  534 131 (24.53)    8 (6.11)  
Military status   4.868 0.027  – –
 Yes 77 16 (20.78)    1 (6.25)  
 No 507 169 (33.33)    6 (3.55)  
Marital status   20.062 0.001  – –
 Married 277 105 (37.91)    3 (2.86)  
 Widowed 55 12 (21.82)    0 (0.00)  
 Divorced 46 11 (23.91)    2 (18.18)  
 Separated 13 2 (15.38)    0 (0.00)  
 Never married 252 58 (23.02)    2 (3.45)  
 Living with partner 34 14 (41.18)    0 (0.00)  
Do you still have a liver condition   4.530 0.033  – –
 Yes  27 3 (11.11)    0 (0.00)  
 No  25 9 (36.00)    0 (0.00)  
Ever told you had cancer or malignancy   4.310 0.038  – –
 Yes  147 32 (21.77)    1 (3.12)  
 No  828 250 (30.19)   10 (4.00)  
Blood relatives have diabetes   4.723 0.030  – –
 Yes  717 222 (30.96)    9 (4.05)  
 No  230 54 (23.48)    2 (3.70)  
Which biological [blood] family member   – –  – 0.093have diabetes?
 Mother 114 31 (27.19)    1 (3.23)  
 Father 63 19 (30.16)    0 (0.00)  
 Mother’s mother 31 6 (19.35)    2 (33.33)  
 Mother’s father 17 6 (35.29)    0 (0.00)  
 Father’s mother 20 8 (40.00)    1 (12.50)  
 Father’s father 9 3 (33.33)    0 (0.00)  
 Brother 90 29 (32.22)    2 (6.90)  
 Sister 204 68 (33.33)    2 (2.94)  
 Other 167 51 (30.54)    1 (1,96)  
Taken antibiotics past month    5.695 0.017  – –
 Yes 54 8 (28.89)    1 (12.50)  
 No  576 174 (30.21)    5 (2.87)  
Take diabetic pills to lower blood sugar   4.229 0.040  – –
 Yes  684 208 (30.41)    6 (2.88)  
 No  323 78 (24.15)    5 (6.41)  
Has the numbness been in hands, feet, or both   5.287 0.071  – –
 Hands 92 20 (21.74)    0 (0.00)  
 Feet 116 41 (35.34)    1 (2.44)  
 Both 144 37 (25.69)    2 (5.41)  
Had a painful sensation or tingling in hands   4.954 0.026  – –or feet past three months
 Yes  353 87 (24.65)    5 (5.75)  
 No  562 177 (31.49)    5 (2.82)  
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(0.00%), levofloxacin (0.00%), rifampin (0.00%), amoxi - 
cillin (0.00%), chloramphenicol (0.00%), doxycycline 
(0.00%), daptomycin (0.00%), quinupristin-dalfopristin 
(0.00%), and linezolid (0.00%). Specially, there was no 
MSSA strain resistant to tetracycline, vancomycin, clin-
damycin, imipenem, cefazolin, oxacillin, gentamicin, 
ciprofloxacin, levofloxacin, rifampin, amoxicillin, chlor - 
amphenicol, doxycycline, daptomycin, quinupristin-
dalfopristin, and linezolid. Moreover, there was no 
MDR S. aureus strain. There were significantly differ-
ences between MRSA and MSSA strains in tetracycline 
(P = 0.012), imipenem (P = 0.007), cefazolin (P = 0.007), 
oxacillin (P < 0.001), levofloxacin (P = 0.007), and amoxi-
cillin (P = 0.070). More details can be found in Table IV.
Toxin characteristics of S. aureus nasal carriage. 
No MRSA strain was positive to SEA while 28.57% of 
MSSA strains were positive to it. No MRSA strain was 
positive to SEB while 4.76% of MSSA strains were posi-
tive to it. 18.18% of MRSA strains were positive to SEC 
while 9.52% of MSSA strains were positive to it. 36.36% 
of MRSA strains were positive to SED while 4.76% 
of MSSA strains were positive to it. Both MRSA and 
MSSA strains were not positive to SEE or SEH. 9.09% 
of MRSA strains were positive to STTS-1 while 38.10% 
Number of days used street drugs over   43.144 < 0.001  – –past year
 < 30 67 20 (29.85)   0 (0.00)  
 30 – 0 0 (0.00)   0 (0.00)  
 90 – 0 0 (0.00)   0 (0.00)  
 180 – 0 0 (0.00)   0 (0.00)  
 270 – 943 266 (28.21)   11 (4.14)  
Ever have five or more drinks every day   4.090 0.043  – –
 Yes  66 12 (18.18)   0 (0.00)  
 No  328 100 (30.49)   2 (2.00)  
 30 – 5 1 (20.00)   0 (0.00)  
 90 – 6 2 (33.33)   0 (0.00)  
 180 – 2 0 (0.00)   0 (0.00)  
 270 – 718 203 (28.27)   11 (5.42)  
Vigorous activity past 30 days   – –  3.279 0.070
 Yes  298 78 (26.17)   0 (0.00)  
 No  421 122 (28.98)   5 (4.10)  
Moderate activity past 30 days   – –  3.039 0.081
 Yes  367 106 (28.88)   1 (0.94)  
 No  362 99 (27.35)    5 (5.05)  
Frequency of playing or exercising hard   – –  3.841 0.050every week
 < 7 92 27 (29.35)   2 (7.41)  
 7 – 112 39 (34.82)   3 (7.69)  
 15 – 4 0 (0.00)   0 (0.00)  
 21 – 2 1 (50.00)   0 (0.00)  
 30 – 800 219 (27.38)   6 (2.74)  
Number of hours using TV, video   – –  9.332 0.002or computer everyday
 None  5 0 (0.00)   0 (0.00)  
 < 1 42 14 (33.33)   0 (0.00)  
 1 47 9 (19.15)   1 (11.11)  
 2 77 27 (35.06)   0 (0.00)  
 3 63 15 (23.81)   0 (0.00)  
 4 32 11 (34.38)   0 (0.00)  
 > 5  67 24 (35.82)   0 (0.00)  
Table I continued
Influencing factors Number of population
Staphylococcus aureus MRSA
Number (%) χ2 PNumber (%) χ2 P
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of MSSA strains were positive to it. With regard to PVL, 
18.18% of MRSA strains were positive to it while no 
MSSA strain was positive to it. There were significantly 
differences between MRSA and MSSA strains in SEA 
(P = 0.049), SED (P = 0.019), TSST-1 (P = 0.083), and 
PVL (P = 0.044). More details can be found in Table V.
Molecular characteristics of MRSA nasal car-
riage. With regard to outcomes of SCCmec type among 
11  MRSA strains, IV (63.64%) was the highest, fol-
lowed by II (27.27), NT (9.09), I (0.00), III (0.00), and 
V (0.00). 63.64% of MRSA strains were CA, 27.27% 
were HA, and 9.09% were NT.
Discussion
This current study comprehensively elucidate the 
prevalence, influencing factors, antibiotic resistance, 
toxin and molecular characteristics of S. aureus and 
Military status  
 Yes 0.371 0.091–1.514
 No 1.00
Ever told you had cancer or malignancy
 Yes  0.255 0.051– 1.286
 No  1.00
Blood relatives have diabetes
 Yes  1.680 0.567–4.982
 No  1.00 
Taken antibiotics past month
 Yes 0.552 0.100–3.045
 No  1.00
Take diabetic pills to lower blood sugar
 Yes  1.797 0.691–4.677
 No  1.00 
Had a painful sensation or tingling in hands
or feet past three months
 Yes  0.359 0.146–0.882
 No  1.00 
Number of days used street drugs over past year
 < 30 1.00 
 30 – – –
 90 – – –
 180 – – –
 270 – 1.951 0.526–7.236
Ever have five or more drinks every day
 Yes  0.317 0.079–1.269
 No  1.00
Table II
Logistic regression analysis of Staphylococcus aureus nasal carriage
OR, Odds Ratio; CI, confidence interval.
95% CIORInfluencing factors
Table III
Logistic regression analysis of MRSA nasal carriage
OR, Odds Ratio; CI, confidence interval.
Gender
 Male  1.00
 Female  3.410 1.091–10.653
Frequency of play or exercise hard every week
 < 7 1.00
 7 – 0.976 0.148–6.427
 15 –   – –
 21 –   – –
 30 – 0.323 0.061–1.722
Influencing factors OR 95% CI
MRSA nasal carriage among diabetic population who 
participated in the NHANES, 2001–2004. Among 1010 
diabetic population in this current study, there were 
286 S. aureus strains, 11 MRSA strains, and 275 MSSA 
strains. The prevalence of S. aureus, MRSA, and 
MSSA nasal carriage were 28.32% (286/1010), 1.09% 
(11/1010), and 27.23% (275/1010) respectively. The 
prevalence of S. aureus (28.32%, 286/1010) nasal car-
riage among diabetic population in this current study 
was lower than that of diabetic outpatient population 
in Turkey (41.78%, 127/304) (Kutlu et al., 2012), that 
of long-term hemodialysis type  2 diabetes patients 
in Saudi Arabia (72.41%, 42/58) (Saxena et al., 2002), 
that of hospitalized diabetic patients in India (56.67%, 
34/60) (Ahluwalia et al., 2000), and that of community-
based diabetes patients in Australia (39.09%, 258/660) 
(Hart et al., 2015), but was higher than that of hospital-
ized diabetic patients (20.50%, 41/200) (Junhua et al., 
2005) and community-based type 2 diabetes patients in 
China (10.31%, 43/417) (Yan et al., 2015). The preva-
lence of MRSA (1.09%, 11/1010) nasal carriage among 
S. aureus diabetic population in this current study was 
lower than community-based type 2 diabetes patients 
in China (5.28%, 22/417) (Yan et al., 2015), that of dia-
betic outpatient population in Turkey (9.87%, 30/304) 
(Kutlu et al., 2012), and that of long-term hemodialysis 
type 2 diabetes patients in Saudi Arabia (18.97%, 11/58) 
(Saxena et al., 2002), but was higher than hospitalized 
diabetic patients in China (0.50%, 1/200) (Junhua et al., 
2005), that of community-based diabetes patients in 
Australia (1.21%, 8/660) (Hart et al., 2015), and that 
of type 1 diabetes pediatric outpatients in Turkey (in 
2005, 0.99%, 1/101; in 2013, 0.75%, 1/134) (Karadag-
Oncel et al., 2015). From the above statistics, we can 
know that the prevalence of S. aureus and MRSA nasal 
carriage among diabetic population were different in 
different countries and regions, and diabetic population 
might be more likely to carry S. aureus and MRSA in 
United States.
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There were studies reported that the main influ-
encing factors of S. aureus and MRSA nasal carriage 
were gender (Geofrey et al., 2015; Soltani et al., 2014; 
Yan et al., 2015), age (Geofrey et al., 2015; Huifen et al., 
2015; Soltani et al., 2014), weight (Campbell et al., 
2015), history of hospitalization (Huifen et al., 2015; 
Karanika et al., 2015), history of invasive operation 
(Karanika et al., 2015; Qiongxiang, 2014), conditions 
of antibiotic using (Qiongxiang, 2014; Soltani et al., 
2014), chronic diseases (Campbell et al., 2015; Chen 
and Pass, 2013; Daeschlein et al., 2015; Geofrey et al., 
2015; Huifen et al., 2015; Karanika et al., 2015), history 
of infection (Chen and Pass, 2013; Daeschlein et al., 
2015) and so on. After performing a logistic regression, 
ever had a painful sensation or tingling in hands or feet 
past three months was still associated with S. aureus 
nasal carriage among diabetic population in this cur-
rent study. Having a  painful sensation or tingling in 
hands or feet past three months was a protective fac-
tor, which might be resulted from more likely of this 
population to notice the hygiene of their hands or feet. 
We found that having a painful sensation or tingling 
in hands or feet past three months among diabetic 
population was 0.359 times less likely than those not 
having a painful sensation or tingling in hands or feet 
past three months to carry S. aureus. With regard to 
Tetracycline  11  3 (27.27) 21  0 (0.00)  6.320  0.012
Clindamycin  11  2 (18.18) 21  0 (0.00) –  0.111
Erythromycin  11  8 (72.73) 21 19 (90.48)  1.725  0.189
Penicillin  11 11 (100.00) 21 19 (90.48) –   0.534
Imipenem  2  2 (100.00) 15  0 (0.00) –    0.007
Vancomycin  11  0 (0.00) 21  0 (0.00) – –
Cefazolin  2  2 (100.00) 15  0 (0.00) –   0.007
Oxacillin  11 11 (100.00) 21  0 (0.00) 32.000 < 0.001
Gentamicin  11  0 (0.00) 21  0 (0.00) – –
Ciprofloxacin  2  0 (0.00) 15  0 (0.00) – –
Levofloxacin  11  3 (27.27) 21  0 (0.00)  6.320  0.012
Rifampin  11  0 (0.00) 21  0 (0.00) – –
Amoxicillin 2  2 (100.00) 15  0 (0.00) –  0.007
Chloramphenicol  9  1 (11.11)  6  0 (0.00) –  1.000
Doxycycline  2  0 (0.00)  1  0 (0.00) – –
Daptomycin  5  0 (0.00)  3  0 (0.00) – –
Quinupristin-dalfopristin  6  0 (0.00)  3  0 (0.00) – –
Linezolid  9  0 (0.00)  6  0 (0.00) – –
Table IV











SEA 6 (18.75) 0 (0.00) 6 (28.57) 3.868 0.049
SEB 1 (3.13) 0 (0.00) 1 (4.76) – 1.000
SEC 4 (12.50) 2 (18.18) 2 (9.52) 0.495 0.482
SED 5 (15.63) 4 (36.36) 1 (4.76) 5.468 0.019
SEE 0 (0.00) 0 (0.00) 0 (0.00) – –
SEH 0 (0.00) 0 (0.00) 0 (0.00) – –
TSST-1 9 (28.13) 1 (9.09) 8 (38.10) 3.004 0.083
PVL  2 (6.25) 2 (18.18) 0 (0.00) 4.073 0.044
Table V
Toxin characteristics of Staphylococcus aureus nasal carriage [n (%)]
SE, staphylococcal enterotoxin; TSST-1, toxic-shock syndrome toxin-1; PVL, panton valentine leukocidin; 
N, number of population; n, number of positive strains.
Toxin Total (N = 32) MRSA (N = 11) MSSA (N = 21) χ2 P
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MRSA nasal carriage among diabetic population in 
this current study, gender was still associated with it in 
this logistic regression model. Female was a risk factor, 
which might be resulted from their weaker immune 
system. Female diabetic population was 3.410 times 
more likely than male diabetic population to carry 
MRSA, which was consistent to a Chinese study (Yan 
et al., 2015) and a Tanzanian study (Soltani et al., 2014). 
Therefore, female diabetic population should be paid 
more attention to perform surveillance of S. aureus and 
MRSA so as to avoid carriage and/or infection.
We found that both MRSA and MSSA strains in this 
current study were highly resistant to erythromycin and 
penicillin, which was similar to several studies (Geofrey 
et al., 2015; Junhua et al., 2005; Kejela and Bacha, 2013; 
Morgenstern et al., 2016) and this might be resulted 
from the extensive use of these antibiotics in medical 
institutions. But both MRSA and MSSA strains were 
100% sensitive to vancomycin, gentamicin, ciprofloxa-
cin, rifampin, doxycycline, daptomycin, quinupristin-
dalfopristin and linezolid, which was similar to several 
studies (Junhua et al., 2005; Morgenstern et al., 2016), 
and it could indicate that these antibiotics can be used 
to treat S. aureus infection in clinical medication. The 
propotions of resistance to tetracycline (P = 0.012), 
imipenem (P = 0.007), cefazolin (P = 0.007), oxacillin 
(P < 0.001), levofloxacin (P = 0.007), and amoxicillin 
(P = 0.070) among MRSA strains were significantly 
higher than MSSA strains. This could indicate that 
the antibiotic resistance of MRSA strains was more 
severe than MSSA strains and should be emphasized by 
healthcare workers. It suggested that healthcare work-
ers should rationally utilize antibiotics, prevent anti-
biotic abuse and long-term use, and can use antibiotic 
combination or rotation to avoid reducing sensitivity 
of S. aureus and MRSA to antibiotics.
The pathogenesis of S. aureus infections depends on 
the production of surface proteins that mediate bacte-
rial adherence to host tissues, secretion of a series of 
extracellular toxins, and enzymes that destruct host 
cells and tissues, avoidance of, or incapacitating, the 
host immune defense, and growth and spread of bac-
teria in host cells (Lowy, 1998). Toxins are proteins 
secreted by S. aureus into the extracellular matrix dur-
ing the post-exponential and early stationary phases. 
These proteins are usually involved in tissue penetration 
and enable the bacteria to invade its host. They are also 
cytolytic and help bacterial growth by acquiring essen-
tial nutrients such as iron from lysed-cells (Kong et al., 
2016). The SEs genes are super antigens which trigger 
T-cell activation and proliferation, and their mode of 
action probably includes activation of cytokine release 
and cell death via apoptosis and potentially lethal toxic 
shock syndrome (Lin et al., 2010). In this current study, 
18.18% and 36.36% of MRSA strains were positive to 
SEC and SED, respectively. 28.57%, 4.76%, 9.52%, and 
4.76% of MSSA strains were positive to SEA, SEB, SEC, 
and SED, respectively. Because SEs can cause vomit-
ing and diarrhea and the toxins are one of the most 
common causes of food-borne diseases (Kong et al., 
2016), we should pay more attention to those who were 
positive to them. It has been reported that TSST-1 will 
stimulate the release of chemokines, such as IL-8 and 
MIP-3α, IL-2, and TNFα (Otto, 2014). Activation of 
immune cells will enhance inflammation and cause 
mucosal cell barrier disruption, allowing further inter-
action of the toxin with T-cells and macrophages, lead-
ing towards toxic shock syndrome (Larkin et al., 1982). 
MSSA (38.10%) strains were more likely than MRSA 
(9.09%) strains to be positive to TSST-1 (χ2 = 3.004, 
P = 0.083), which meant that those who carried MSSA 
should be paid more attention. PVL has been reported 
to be associated with CA-MRSA infections (Otto, 2010), 
which was consistent with this current study. 28.57% 
(2/7) of CA-MRSA strains in this current study were 
positive to it. 18.18% of MRSA strains were positive to 
PVL, which was higher than health care personnel in 
Egypt (2.24%, 5/223) (Hefzy et al., 2016) and patients 
in Indonesia (6.56%, 17/259) (Santosaningsih et al., 
2016), which might be resulted from poor hand hygiene 
compliance and non-judicious use of antibiotics.
Among 11 MRSA strains, seven (63.63%) were CA, 
three (27.27%) were HA, and one (9.09%) was NT, 
which could indicate that the majority of MRSA strains 
in this current study were from community and rel-
evant departments should pay attention to strengthen 
the surveillance and disinfection in community.
Overall, there were several limitations in this cur-
rent study. Firstly, we did not take the environmental 
characteristics into consideration due to the complex 
data due to limited financial support. Secondly, we 
did not follow up the outcome of the included popu- 
lation due to the limited data, which can be studied 
in the future. Thirdly, there are limited data on the 
antibiotic resistance, toxin, and molecular characteris-
tics of S. aureus and MRSA, which might lead to some 
kind of errors.
Conclusions
Diabetic population might be more likely to carry 
S. aureus and MRSA in United States. Having a painful 
sensation or tingling in hands or feet past three months 
might be a protective factor. Female might be a risk fac-
tor and female diabetic population should be paid more 
attention to perform surveillance of S. aureus and MRSA 
so as to avoid carriage and/or infection. The antibiotic 
resistance of MRSA strains was more severe than that 
of MSSA strains and should be emphasized by health-
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care workers. The proportions of toxins in S. aureus 
were high and those who detected positive should be 
paid more attention. Therefore, improving compliance, 
reducing antibiotic overuse, screening for carriers, and 
decolonization are recommended strategies for reduc-
ing the spread of S. aureus and MRSA. The majority of 
MRSA strains in this current study were from com-
munity and relevant departments should pay greater 
attention to strengthen the surveillance of S. aureus and 
MRSA and disinfection measures in community.
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